Last updated: 17 Jun, 2020 | 04:49 pm
Pharma industry in India
Challenging times in last 5 years
However, FY20 has registered a flat growth and FY21 could see a 5% growth, according to forecasts. Analysts are now very bullish on the sector and say that earnings could double in 4 to 5 year period.
Robust rally in pharma sector
While the ongoing pandemic has led to a steep correction in stocks of other industries, pharma companies have rallied by up to 70% since the lockdown was announced on March 24th. The table below shows the handsome gains made by some of the drugmakers since the lockdown began.
What has led to this massive rally?
Prospects going forward
Our VGQM model has a Buy rating on Cadila Healthcare, Divi’s Lab, Dr Reddy’s and Torrent Pharmaceuticals.
Looking to invest in stocks? Reach out to your personal family wealth office by clicking on the Ask Advisor button!